Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.31% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ETON · Mar 31, 2026
Eton Pharmaceuticals, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001437749-26-017064General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
30.52% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
40.41% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
59.62% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
60.72% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
9.95% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.73% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
6.26% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/8 normalizedLevel 3Sep 30, 20250/8 normalizedLevel 3Dec 31, 20257/9 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20267/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.42%
- Current
- 0.31%
- Delta
- -0.11%
- Previous
- 13.16%
- Current
- 30.52%
- Delta
- 17.35%
- Previous
- 104.94%
- Current
- 40.41%
- Delta
- -64.53%
- Previous
- 19.29%
- Current
- 59.62%
- Delta
- 40.33%
- Previous
- 53.46%
- Current
- 60.72%
- Delta
- 7.26%
- Previous
- -1.06%
- Current
- 9.95%
- Delta
- 11.00%
- Previous
- 9.71%
- Current
- 7.73%
- Delta
- -1.99%
- Previous
- 6.89%
- Current
- 6.26%
- Delta
- -0.64%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Has State · Eton Pharmaceuticals, Inc. →Transitioned To · ETON Fundamental State →Transitioned To · ETON CAPEX_INTENSITY_DECREASED →Transitioned To · ETON CASH_GENERATION_INCREASED →Transitioned To · ETON GROWTH_DECREASED →Transitioned To · ETON INVENTORY_PRESSURE_INCREASED →Transitioned To · ETON MARGIN_INCREASED →Transitioned To · ETON PROFITABILITY_INCREASED →Transitioned To · ETON R_AND_D_INTENSITY_DECREASED →Transitioned To · ETON SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.